Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: Results from a meta-analysis [5]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 3, 2007, Pages 621-623

  Caruso, V ^a   Iacoviello, Licia ^a   Di Castelnuovo, A ^a   Storti, S ^a   Donati, M B ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; BACTERIAL ENZYME; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ESCHERICHIA COLI ASPARAGINASE; IDARUBICIN; PREDNISONE; STEROID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GLUCOCORTICOID;

ACUTE LYMPHOBLASTIC LEUKEMIA; BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; GENETIC DISORDER; HIGH RISK POPULATION; HUMAN; INCIDENCE; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT DURATION; VEIN THROMBOSIS; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; CHEMICALLY INDUCED DISORDER; REMISSION;

ADULT; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; REMISSION INDUCTION; VENOUS THROMBOSIS;

EID: 34247573986     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02383.x     Document Type: Letter

References (17)

1. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB. Thrombotic complications in childhood acute lymphoblastic leucemia. A meta-analysis of 17 prospective studies comprising 1,752 pediatric patients. Blood 2006; 108: 2216-22.
2. Viganò-D'Angelo S, Gugliotta L, Mattioli Belmonte M, Cascione ML, Pattarini E, D'Angelo A. L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation. Thromb Res 1990; 59: 985-94.
3. Castaman G, Rodeghiero F, Dini E. Thrombotic complications during l -asparaginase treatment for acute lymphocytic leukemia. Haematologica 1990; 75: 567-9.
4. Mazzucconi MG, Gugliotta L, Leone G, Dragoni F, Belmonte MM, De Stefano V, Chistolini A, Tura S, Mandelli F. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli l -asparaginase. A GIMEMA study. Blood Coagul Fibrinolysis 1994; 5: 23-8.
5. Carlsson H, Stockelberg D, Tengborn L, Braide I, Carneskog J, Kutti J. Effects of Erwinia-asparaginase on the coagulation system. Eur J Haematol 1995; 55: 289-93.
6. Nocentini F, Gugliotta L, Catani L, Vianelli N, Baravelli S, Martelli V, Tura S. Negligible hemostatic toxicity of intermediate-dose erwinase in adult patients with acute lymphoblastic leukemia: Preliminary data. Haematologica 1994; 79: 546-9.
7. Pogliani EM, Parma M, Baragetti I, Mostarda G, Rivolta F, Maffe P, Corneo G. l -asparaginase in acute lymphoblastic leukemia treatment: The role of human antithrombin III concentrates in regulating the prothrombotic state induced by therapy. Acta Haematol 1995; 93: 5-8.
8. Leone G, Gugliotta L, Mazzucconi MG, De Stefano V, Belmonte MM, Dragoni F, Specchia G, Centra A, Gamba G, Camera A. Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli l -asparaginase: A GIMEMA study. Thromb Haemost 1993; 69: 12-5.
9. Bassan R, Battista R, D'Emilio A, Viero P, Dragone P, Dini E, Barbui T. Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia. Eur J Cancer 1991; 27: 441-7.
10. Liebman HA, Wada JK, Patch MJ, McGehee W. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with l -asparaginase. Cancer 1982; 50: 451-6.
11. Castaman G, Rodeghiero F. Erwinia- and E. coli -derived l -asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia. Haematologica 1993; 78: 57-60.
12. Barbui T, Rodeghiero F, Meli S, Dini E. Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during l -asparaginase therapy. Acta Haematol 1983; 69: 188-91.
13. De Stefano V, Sora F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G. The risk of thrombosis in patients with acute leukemia: Occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005; 3: 1985-92.
14. Barbui T, Finazzi G, Viganò S, Mannucci PM. l -asparaginase lowers Protein C antigen. Thromb Haemost 1984; 52: 216.
15. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl) 2005; 14: 53-62.
16. Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: An underestimated phenomenon. Arch Intern Med 2004; 164: 190-4.
17. Jabbour EJ, Faderl S, Kantarjian HM. Adult acute lymphoblastic leukemia. Mayo Clin Proc 2005; 80: 1517-27.